news paper icon

Analyzed News

BRIEF-Advaxis Submits Conditional MAA For Second-Line Metastatic Cervical Cancer Treatment In European Union

* ADVAXIS SUBMITS CONDITIONAL MARKETING AUTHORIZATION APPLICATION FOR AXALIMOGENE FILOLISBAC FOR THE SECOND-LINE TREATMENT OF METASTATIC CERVICAL CANCER IN EUROPEAN UNION [Source]

Publication Date:

Origin: reuters.com

Category: companyNews

Topics: european, cancer, cervical, second-line, submits

Source Link: http://feeds.reuters.com/~r/reuters/companyNews/~3/IMtcbJ3_4b0/brief-advaxis-submits-conditional-maa-for-second-line-metastatic-cervical-cancer-treatment-in-european-union-idUSFWN1Q30ZZ

Related Articles